scholarly journals Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study

2021 ◽  
Author(s):  
Yuki Kageyama ◽  
Yasuhiko Deguchi ◽  
Kotaro Hattori ◽  
Sumiko Yoshida ◽  
Yu‐ichi Goto ◽  
...  
2017 ◽  
Vol 107 ◽  
pp. 424-428 ◽  
Author(s):  
Norbert Wąsik ◽  
Bartosz Sokół ◽  
Marcin Hołysz ◽  
Witold Mańko ◽  
Robert Juszkat ◽  
...  

2019 ◽  
Vol 71 (1) ◽  
pp. 15-20
Author(s):  
Nicolaas A. Verwey ◽  
Charlotte E. Teunissen ◽  
Jeroen J.M. Hoozemans ◽  
Annemieke J.M. Rozemuller ◽  
Philip Scheltens ◽  
...  

2005 ◽  
Vol 187 (1) ◽  
pp. 87-88 ◽  
Author(s):  
Mark S. Bauer ◽  
Gregory E. Simon ◽  
Evette Ludman ◽  
Jurgen Unützer

SummaryCross-sectional analysis of 441 individuals with bipolar disorder treated at a US health maintenance organisation investigated the distribution of manic and depressive symptoms in that illness. Clinically significant depressive symptoms occurred in 94.1% of those with (hypo)mania, while70.1% inadepressive episode had clinically significant manic symptoms. DSM-unrecognised depression-plus-hypomania was over twice as prevalent as DSM-recognised mixed episodes. Depressive symptoms were unimodally distributed in (hypo)mania. Depressive and manic symptoms were positively, not inversely correlated, and their co-occurrence was associated with worse quality of life. Implications for the DSM and ICD nosological systems are discussed.


2016 ◽  
Vol 40 (2) ◽  
pp. 123-130
Author(s):  
Hiroshi Ooyama ◽  
Keiko Ooyama ◽  
Hitoshi Moromizato ◽  
Norifumi Takagi ◽  
Yuki Tashiro ◽  
...  

BMC Cancer ◽  
2007 ◽  
Vol 7 (1) ◽  
Author(s):  
B Hildebrandt ◽  
C Müller ◽  
A Pezzutto ◽  
PT Daniel ◽  
B Dörken ◽  
...  

2016 ◽  
Vol 209 ◽  
pp. 119-124 ◽  
Author(s):  
M. Girod ◽  
F. Allerton ◽  
K. Gommeren ◽  
A.C. Tutunaru ◽  
J. de Marchin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document